The theory that suggests common viral or bacterial infections could potentially cause Alzheimer’s disease has left many patients on edge. While this so-called “Fringe Theory” linking viruses and other microbes to Alzheimer’s was first proposed more than 30 years ago, it has gained traction over the past several years.
While we do know the immune system plays a key role in the development of Alzheimer’s disease, there is not enough evidence to support a hypothesis that suggests Alzheimer’s is caused by viruses or other types of infections.
Below, we provide information on the theory that Alzheimer’s is caused by viruses, detailing the infectious hypothesis, types of infections claimed to cause Alzheimer’s disease, and known factors involved in Alzheimer’s development.
The infectious hypothesis suggests that some sort of pathogen (such as a virus, bacteria, or prion) is the underlying root cause of Alzheimer’s disease. The theory stems primarily from evidence that some pathogens, such as herpesviruses, are more commonly found in the brains of Alzheimer’s disease patients compared to those without Alzheimer’s.
A few of the infections and viruses being researched due to their connection to Alzheimer’s disease include herpes, pneumonia, and spirochete bacteria.
Herpes simplex virus 1 (HSV-1), also known as oral herpes, causes an infection of the mouth in the form of cold sores. This virus stays in the body for life but remains dormant most of the time. While HSV-1 typically infects the body, it has been found in the brains of both healthy individuals and those with Alzheimer’s disease. However, the HSV-1 virus seems to be more common in those with Alzheimer’s disease who have a risk gene for Alzheimer’s, APOE ε4.
Chlamydia pneumoniae is a respiratory pathogen that causes pneumonia and bronchitis. While it typically infects the respiratory tract, the passage formed by the mouth, nose, throat, and lungs, it can sometimes remain as a chronic infection inside cells. Because this bacteria has been found in the brains of those with Alzheimer’s disease, some researchers have hypothesized that the inflammation caused by the presence of this bacteria may contribute to underlying pathological mechanisms of Alzheimer’s.
Spirochetes, such as Borrelia burgdorferi, which causes Lyme disease, and Porphyromonas gingivalis, which causes gum disease, have also been linked to Alzheimer’s disease. Spirochetes are significantly more common in the brains of those with Alzheimer’s disease compared to those without Alzheimer’s. Additionally, chronic gum disease has been identified as a risk factor for Alzheimer’s.
While there is currently no known causative agent for Alzheimer’s disease, there are many well-known risk factors. Alzheimer’s disease is believed to be multifactorial, meaning it is not caused by a single factor, like a virus, but rather develops from a combination of several factors, such as age, genetics, and lifestyle, as detailed below.
The truth is you can find correlations between any two things. Just because viruses and other infections are more commonly found in patients with Alzheimer’s disease does not necessarily mean that Alzheimer’s is caused by viruses. Correlation does not imply causation. This is not to say that these viruses have no bearing on Alzheimer’s disease; however, it is more likely that the higher prevalence of such infections in Alzheimer’s disease patients is caused by the higher susceptibility to infection for those with the disease.
To better understand and address the breadth of factors involved in Alzheimer’s disease development, more research will be required in addition to the application of precision medicine approaches. Taking a more precise, personalized approach to neurological diseases, like Alzheimer’s disease, will give rise to a wide range of targeted drugs and therapies that can be effectively used in combination to treat specific neurocognitive impairments (impairments to cognitive and functional aspects of brain function) that present uniquely in neurological disease patients.
At Altoida, we are dedicated to bringing precision medicine approaches to neurological disease diagnosis and monitoring. We are building the world’s-first Precision Neurology platform and app-based medical device—backed by 11 years of clinical validation—to accelerate and improve drug development, neurological disease research, and patient care.
By completing a series of augmented reality and motor activities designed to simulate complex Activities of Daily Living on a smartphone or tablet, Altoida’s device extracts and provides robust measurements of brain function across 13 neurocognitive domains. Our device measures and analyzes nearly 800 multimodal cognitive and functional digital biomarkers. Through the collection of highly granular data from integrated smartphone or tablet sensors, Altoida’s device produces comprehensive neurocognitive domain scores.
This method, along with our innovative artificial intelligence, will pioneer fully digital predictive neurological disease diagnosis. After our Breakthrough Device designation by the FDA, Altoida’s device will provide patients with a predictive score that will enable a highly accurate prediction of whether a patient aged 55 and older will or will not convert from Mild Cognitive Impairment to Alzheimer’s disease.
When this score is taken in conjunction with our neurocognitive domain scores, providers will be able to make specific, personalized conclusions about how neurological diseases are uniquely affecting their patients. This, in turn, will enable a personalized precision approach to treatment and care plan development for neurological disease patients.
To learn more about if Alzheimer’s is caused by viruses or about Altoida’s Precision Neurology platform and medical device, contact us today.